Selected Publications

Ogg GS, P.R. Dunbar P, Romero P, Chen JL, Cerundolo V High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med 1998 Sep 21;188(6):1203-8, 1998.

Romero, P., P. R. Dunbar, D. Valmori, M. Pittet, G. S. Ogg, D. Rimoldi, J. L. Chen, D. Lienard, J. C. Cerottini, and V. Cerundolo. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen- experienced tumor-specific cytolytic T lymphocytes. J Exp Med 1998, 188:1641, 1998.

Valmori D, Gileadi U, Servis C, Dunbar PR, Cerottini JC, Romero P, Cerundolo V, Levy F Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.J Exp Med Mar 15;189(6):895-906, 1999

Dunbar, P., C. Smith, D. Chao, M. Salio, D. Shepherd, F. Mirza, M. Lipp, A. Lanzavecchia, F. Sallusto, A. Evans, R. Russell-Jones, A. Harris, and V. Cerundolo.A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune respons. J Immunol 165:6644, 2000.

Chen, J., Dunbar, R., Gileadi, U., Jager, E., Gnjatic S., Nagata Y., Stockert, E., Panicali, D.L., Chen Y-T., Knuth, A., Old, L.J., Cerundolo, V. Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor reactive cytotoxic T lymphocytes. J. Immunol. 165:948-955, 2000